Private Equity: An opportunity biopharma should seize
Private equity investment in biopharma Private equity investment in biopharma is surging. Although private equity firms have been investing in biopharma for years it is the nature of this surge that is interesting. Private equity is increasingly focusing on two activities: Providing growth capital – biopharma companies reaching critical late-stage development or growth juncture seeking […]